基于专利合作网络的我国中药合作创新研究

Research on collaborative innovation in traditional Chinese medicine of China based on patent cooperation network

全球竞争的新形势下,合作创新已成为创新主体规避创新风险和提高创新能力的重要选择之一。为探索我国中药研究领域中的合作创新模式及其演化路径,该研究采用科学计量学和社会网络分析等方法,对我国1985—2013年中药专利合作进行了深入剖析。研究发现,1虽然近年来我国以国内研发力量为主导的中药合作专利在数量上保持快速增长,但总体而言,我国中药合作创新程度并不高,合作规模也较小;2"个人+个人"曾是国内中药合作创新的最主要方式,但随着时间推移,机构主体逐渐崛起并在国内中药合作创新中取得重大突破;3以高校为代表的核心机构在当前国内机构间的中药合作创新中发挥了举足轻重的战略作用,不仅成为连接众多其他机构的关键纽带,促进了知识的转移和扩散,更在未来拥有重大发展潜力。

In the situation of global completion,collaborative innovation is becoming increasingly important because its advantage in risk avoiding and innovation efficiency. In order to explore the model of collaborative innovation and its evolution in traditional Chinese medicine of China,the cooperation in traditional Chinese medicine patents of China from 1985 to 2013 has been analyzed by using the method of scientometrics and social network analysis. It is proved that,though the number of grated cooperative patents has increased sharply during the last thirty years,the degree of cooperation innovation in traditional Chinese medicine of China is still not high. Moreover,in spite of the individual subject＇s leading role in the past domestic collaborative innovation in traditional Chinese medicine of China,the institutions have been more and more powerful and achieved great improvement. At last,core institutions,represented by universities have played an important role in the collaborative innovation of domestic institutions,because they are key links between many institutions and promote the transferring and diffusion of knowledge.